163 related articles for article (PubMed ID: 14691910)
1. Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors.
Takahashi E; Tateyama H; Akatsu H; Fukai I; Yamakawa Y; Fujii Y; Eimoto T
Hum Pathol; 2003 Dec; 34(12):1253-8. PubMed ID: 14691910
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between MMP-2 activation and MT1-MMP mRNA expression in thymic epithelial tumors].
Wang Y; Ueda Y; Shimasaki M; Liu N; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):18-23. PubMed ID: 16608644
[TBL] [Abstract][Full Text] [Related]
3. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors.
Sogawa K; Kondo K; Fujino H; Takahashi Y; Miyoshi T; Sakiyama S; Mukai K; Monden Y
Cancer; 2003 Nov; 98(9):1822-9. PubMed ID: 14584061
[TBL] [Abstract][Full Text] [Related]
5. Activation ratio of MMP-2 and expression of MT1-MMP are correlated in thymic epithelial tumours.
Wang Y; Xu HT; Ueda Y; Shimasaki M; Wang EH
Pathology; 2007 Oct; 39(5):486-90. PubMed ID: 17886098
[TBL] [Abstract][Full Text] [Related]
6. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
9. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
Davidson B; Goldberg I; Kopolovic J; Lerner-Geva L; Gotlieb WH; Ben-Baruch G; Reich R
Gynecol Oncol; 1999 Jun; 73(3):372-82. PubMed ID: 10366463
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Schwandner O; Schlamp A; Broll R; Bruch HP
Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas.
Masaki T; Sugiyama M; Matsuoka H; Abe N; Izumisato Y; Sakamoto A; Atomi Y
Anticancer Res; 2003; 23(5b):4169-73. PubMed ID: 14666620
[TBL] [Abstract][Full Text] [Related]
13. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
Katayama A; Bandoh N; Kishibe K; Takahara M; Ogino T; Nonaka S; Harabuchi Y
Clin Cancer Res; 2004 Jan; 10(2):634-40. PubMed ID: 14760086
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase-2, -9, -14, and tissue inhibitors of metalloproteinase-1, -2, -3 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy.
Wang H; Li Q; Shao L; Zhu C
Biol Reprod; 2001 Jul; 65(1):31-40. PubMed ID: 11420220
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Suzuki M; Iizasa T; Fujisawa T; Baba M; Yamaguchi Y; Kimura H; Suzuki H
Invasion Metastasis; 1998-1999; 18(3):134-41. PubMed ID: 10474026
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-2, -9, and -14, tissue inhibitors of metalloproteinase-1, and matrix proteins in human placenta during the first trimester.
Xu P; Wang YL; Zhu SJ; Luo SY; Piao YS; Zhuang LZ
Biol Reprod; 2000 Apr; 62(4):988-94. PubMed ID: 10727268
[TBL] [Abstract][Full Text] [Related]
17. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
18. [Histologic subtyping and prognosis of thymoma: a study of 108 cases].
Jiao X; Yin HL; Lu ZF; Zhao YC; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):445-9. PubMed ID: 19035114
[TBL] [Abstract][Full Text] [Related]
19. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
20. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
Cardillo MR; Di Silverio F; Gentile V
Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
